Remote Monitored Systems Share Discussion Threads

[julianw2] 12/11/2020 11:46

That's annoying won't let me buy any large amounts :(

[jayminpatel1] 12/11/2020 11:41

Old boxer dog was dumping pmsl while telling all he wasnt

[chesty1] 12/11/2020 11:34

Very well done Volsung!

[zxie] 12/11/2020 11:33

Strong bad weather

[volsung] 12/11/2020 11:27

Sold a 20% of my holding at 2.9p this morning. Bought some of those back now for 2.3p

[shouldhavesold] 12/11/2020 11:27

Very high risk trading share, wasn’t expecting the correction over past two days especially as not a particularly different statement to one the previously. Directors seem to be playing it well with options granted at bottom again. They will sell at first opportunity going by the recent past and BRH are likely to sell more as they work their exit and also the 10% shareholder and recently conv warrant holders who are on a big ol profit. Just my thoughts DYOR

[kemche] 12/11/2020 11:26

They are only allowing selling FFS!

[chesty1] 12/11/2020 11:21

Every time they drop it you cannot buy!

[kemche] 12/11/2020 11:18

But not on Tuesday.
Non sequiturs are us.

[amrishbhim] 12/11/2020 11:16

I agree but it's only the morning

[kemche] 12/11/2020 11:12

I think a combination of naivete and stupidity, in equal measure, is a dangerous mix when it comes to investing.

Apropos nothing of course.

[kemche] 12/11/2020 11:09

I is glad at least you is knowing what you is sayings for once's because I am befudllings! You have out the numbers but I have inned the numbers also.
Nothing is perfect - certainly not here.

[amrishbhim] 12/11/2020 11:06

I think I know what I'm saying, I'm talking about bonus not about a salary, I just don't see any reason about them selling some shares, if you are disappointed to the fact the price are down than kemche that's up to you, I've out the numbers, everyone can do some background checks or research, I'm not promoting this or any company just positive about it, Do you think the the news regarding the COVID 19 testing company that came few days after trump lost, suddenly everything is perfect, I don't, I believe a company in England or France will develop it first and be able to deliver better, but look at how the market reacted

[smart solution] 12/11/2020 11:06

INSP about to go north again...

[kemche] 12/11/2020 11:05

Agreed julian, just a ruse to collect cheap shares by the MMs at the expense of naive investors.

[julianw2] 12/11/2020 11:03

Just a little shake, in my opinion, this follows the same old pattern.

[kemche] 12/11/2020 10:58

BOD is not taking bonuses???? You have not seens Trevor Brown's backgrounds??? What is research is you doings?? BODS is profit takings???? WTF is you sayings????

[amrishbhim] 12/11/2020 10:55

BRH has a reason, it's a venture company, BOD due to profit taking because like us all there have reason to sell some, these guys haven't been taking any bonuses for many years. I don't see a problem

[kemche] 12/11/2020 10:51

Once's the common are others but they 99.99% effective, the once's rms is proof of concept but not production yet let alone onc'es sales yet. But belief of £52m orders is just beliefs of once's - not reality as yets. But why is BRH and BODS is selling???

[amrishbhim] 12/11/2020 10:47

Scientists develop facemask which can kill viruses on contactA new antiviral facemask which uses nanotechnology to kill viruses including COVID-19 and influenza has been designed and developed by a Nottingham Trent University scientist.Scientists develop facemask which can kill viruses on contactAntiviral facemaskTests showed the masks were highly effective, at killing more than 90% of the influenza and coronavirus over seven hoursInstead of the usual three-ply design, the five-ply surgical mask includes an additional antiviral inner layer which incorporates nano-copper created using a patented process developed at the university. The copper, which is embedded into the mask material, has ions that are emitted once in contact with a virus and this then creates an interaction with the virus's genetic material causing it to die and stop reproducing. Because they are spherical, nanoparticles have a large surface area making the approach more effective at killing the virus. The antiviral inner layer ensures additional protection for both the wearer and those in proximity.The mask has been designed by Nottingham Trent University scientist and nanotechnology expert, Dr Gareth Cave, and is now being commercialised by NTU spin out company Pharm2Farm in Nottingham's BioCity. The company, which was founded by Dr Cave, uses a patented process to produce and functionalise nanoparticles for a range of human, crop and animal health benefits. Tests showed that the masks, which are Type IIR – meaning they offer the highest level of protection and have a filtration efficiency of 99.98% – were highly effective, at killing more than 90% of the influenza and coronavirus over seven hours, and have been certified to ISO 18184 standards.The masks include a fluid-repellent layer on the outside - to reduce inhalation of droplets of saliva and mucus that carry COVID-19 – the antiviral nanotech layer between two filter layers, and a hypoallergenic breathable innermost layer.While current conventional surgical masks block the virus, it can remain on or in the mask while being worn and after it has been disposed of. The masks are expected to go into production in Nottingham later this month and will be commercially available from December for healthcare, transport and food service settings initially.Facemask and boxDespite the additional layer and the antiviral properties, the masks will be in line with current Type IIR mask prices. "It's exciting to see our technology move forward and make a real impact towards the fight against the spread of COVID-19," said Dr Cave, who is based in Nottingham Trent University's School of Science and Technology. He said: "The mask we've developed has been proven to inactivate viruses upon contact; the antiviral layer kills virus which has been blocked by the filter layers. The challenge with conventional surgical-type masks is that they only block virus from entering or exiting the mask. They don't have an active mechanism for killing it once it's trapped in the mask. "Our new antiviral mask has been designed to utilise the existing barrier technology and combine it with our nanotechnology to kill the virus once it is trapped there. "We've added the barrier layer to both sides of the mask so not only does it protect the wearer but also those around. By killing the virus on contact, it also means that the used face mask can be safely disposed of and not be a potential source of passive transfer."The masks have been designed and tested following an Innovate UK grant, as part of UK Research and Innovation's response to COVID-19.